Schulz Fran
SEC insider (Form 3/4/5 filer). CIK 0002046804. Director at EDAP TMS SA (FOCL) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in LOS ALTOS,, CA.
Companies Schulz Fran has filed insider reports for
- EDAP TMS SA (FOCL): Director
- Senti Biosciences, Inc. (SNTI): Director
Schulz Fran
CIK: 0002046804
Transaction Breakdown
Open Market Buys (P)1 (25.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (75.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Aug 14, 2026FOCL
EDAP TMS SA
PurchaseDirect10K shares at avg. $4.75$48K - Jun 25, 2025SNTI
Senti Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
22K shares- - Mar 7, 2025SNTI
Senti Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
43.9K shares- - Dec 9, 2024SNTI
Senti Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
12.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 14, 2026 |  FOCL EDAP TMS SA | Purchase | 10,000 | $4.75 | $47,500 | Direct |
| Jun 25, 2025 |  SNTI Senti Biosciences, Inc. | Award Stock Option (Right to Buy) | 21,950 | - | - | Direct |
| Mar 7, 2025 | SNTI Senti Biosciences, Inc. | Award Stock Option (Right to Buy) | 43,900 | - | - | Direct |
| Dec 9, 2024 | SNTI Senti Biosciences, Inc. | Award Stock Option (Right to Buy) | 12,500 | - | - | Direct |
1-4 of 4 transactions